Venous thrombo-embolic events (VTE) are a classic complication of orthopaedic and trauma surgery. Traditionally, their prevention has been based on the routine prescription of potent anticoagulants. More recently, the recognition of the iatrogenic complications of anticoagulant therapy, the advent of rapid recovery or fast-track procedures, and the consequent assumption of reduced risk of postoperative VTE, have led to a more general reflection on the benefit/risk balance of prophylaxis through anticoagulant treatment.Patient-related VTE risk factors include (but are not limited to):previous or family history of venous thromboembolism 1,2 major thrombophilia 3 age >70 years 4 obesity 5 hypoalbuminaemia 6 active cancer 7 oestrogenic oral contraception and oral hormone therapy for the menopause 8 renal insufficiency 9Risk factors for VTE associated with surgery include (but are not limited to): surgery on the lower limb, especially pelvic, hip, knee 10 long duration of surgery 11 cast immobilisation 12 allogenic blood transfusion 13 use of tourniquet 14 Patient-related bleeding risk factors include (but are not limited to): coagulopathy 15 anticoagulant medication 16 Bleeding risk factors related to the procedure performed are (but are not limited to): duration of procedure 17 length of skin incision 18 use of drains 19 The prescription of prophylactic treatment must be based on a synthesis of these different elements. Prescription must be tailored for each patient and each procedure, and no universal approach can be proposed.Fast-track procedures aim to reduce the duration of a hospital stay by delivering optimised patient-centred care to achieve a pain and risk-free surgery. 20 These pathways reduce the risk of postoperative VTE in orthopaedics 21 and should be used routinely as there are no real contraindications, particularly to early resumption of walking, which is probably the major factor preventing VTE. 22,23